Is Soros Behind
the War on Hydroxychloroquine?
Breaking Israel News
Latest News Biblical perspective
By Adam Eliyahu Berkowitz May 24, 2020
“All kinds of trees for food will grow up on both banks
of the stream. Their leaves will not wither nor their fruit fail; they will
yield new fruit every month, because the water for them flows from the Temple.
Their fruit will serve for food and their leaves for healing.” Ezekiel 47:12
(The Israel Bible™)
George Soros, Founder and Chairman of the Open Society
Foundation gives a speech during Economic Forum in Brussels, Belgium on June 1,
2017 (courtesy: Shutterstock)
Even though many lives are at stake, the response to the
coronavirus pandemic has been heavily politicized. A bit of research into the
separate elements shows some disturbing connections, indicating the media war
against hydroxychloroquine may be backed by some nefarious forces.
THE REMDESIVIR VERSUS HYDROXYCHLOROQUINE TIMELINE
On March 19, President Trump announced that the
FDA would fast-track approval of unproven coronavirus treatments, including
hydroxychloroquine. Two months later, after much heated debate and a media war
over the drug, Trump announced he was taking hydroxychloroquine as
prophylaxis.
One week after Trump’s hydroxychloroquine claim, the Food
and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for
emergency use of remdesivir for the treatment of COVID-19 patients. Remdesivir
is currently being tested as the only specific treatment for COVID-19, and has
been authorized for emergency use in the U.S. and approved for use in Japan for
people with severe symptoms.
Remdesivir was originally created and developed by Gilead
Sciences in 2009. Originally intended as a treatment for hepatitis C for which
it was unsuccessful, remdesivir was later studied as a potential treatment for Ebola virus
disease. In January 2020, Gilead began laboratory testing of remdesivir for
treating COVID-19.
On 21 January, the Wuhan Institute of
Virology applied for a Chinese “use patent”, for treating COVID‑19.
At the time, no research had been published showing that remdesivir was
effective. Even so, the drug was already being deployed for clinical
trials in Wuhan and elsewhere in China.
On January 21, the same day the Wuhan Institute of
Virology, part of the China Academy of Sciences, applied for the “use patent”
remdesivir, the Chinese president
allegedly made a phone call to the director of the WHO,
pressuring him to delay declaring the coronavirus to be a pandemic.
REMDESIVIR: CHINESE OR AMERICAN?
The FDA authorization states that the distribution
of remdesivir will be controlled by the United States (U.S.) Government.
Indeed, Gilead lists its headquarters as being located in Foster City,
California, but it also has a branch in Shanghai and announced that it is
partnering with the Chinese Health Authorities on the clinical trials of
remdesivir.
WUXI Pharmatech was
formed out of the combination of Chinese WuXi PharmaTech and American AppTec
Laboratory Services, which had centers in Minnesota, Pennsylvania, and Georgia.
THE SOROS MONEY CONNECTION
Documents from the
Securities and Exchange Commission in 2011 show Soros Fund Management LLC
invested heavily into WUXI Pharmatech Caymen, Inc.,
a pharmaceutical and biotechnology company. In 2012, WuXi AppTec opened a
Research and Development center in Wuhan. In 2015, Wuxi teamed with Gilead
Scinces in establishing a dedicated analytical and stability testing facility
in Shanghai.
WuXi AppTec operates 15 sites across the U.S., Europe,
and the Middle East. One year before Soros invested
in the company, they announced plans to build a $100 million research and
development center in Wuhan. The center was opened one year after
Soros’ investment, the Wuhan lab was opened.
In 2012, Soros Management also invested in Gilead
Sciences, though the extent of that investment is not known.
SOROS SUPER PAC ATTACKING PRO-HYDROXYCHLOROQUINE TRUMP
Last month, the Washington Free Beacon reported
that Priorities USA Action, the
Democratic Party’s largest super PAC, will spend tens of millions on
advertisements criticizing Trump for his response to the coronavirus pandemic.
According to the report, Priorities USA Action received $3 million in
contributions from Soros’s political organization on Feb. 21. Soros’s donation
accounts for 77 percent of the $3.9 million
Priorities USA Action reported receiving last month.
Other Democratic political funds linked to Speaker othe
House Nancy Pelosi, former Secretary of State Hillary Clinton, and Democratic
Presidential candidate Joe Biden are following suit, investing heavily in
politicizing the pandemic.
WHY REMDESIVIR AND NOT HYDROXYCHLOROQUINE?
Neither drug has been thoroughly tested though there is a
significant difference between them. Remdesivir is administered intravenously
for 5-10 days.Gilead owns the patent and though they have not announced their
projected price for the drug, it is estimated they will charge between
$390-$4,000 for a full course of the drug.
Hydroxychloroquine has was approved for medical use in
the United States in 1955 and has no exclusive patents. As such, it costs about
60 cents per pill.
No comments:
Post a Comment